Prof Karl HerholzMD, FRCP

Professor

Full contact details
View graph of relations

Publications

  1. 2019
  2. E-pub ahead of print

    Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies

    IMBI Brain Imaging Working Group, 16 Apr 2019, In : Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 11, p. 327-332 6 p.

    Research output: Contribution to journalArticle

  3. E-pub ahead of print

    Harmonization of neuroimaging biomarkers for neurodegenerative diseases: A survey in the imaging community of perceived barriers and suggested actions

    SRA-NED JPND Working Group, 10 Jan 2019, In : Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 11, p. 69-73 5 p.

    Research output: Contribution to journalArticle

  4. Published

    [18F]Florbetapir Positron Emission Tomography: Identification of Muscle Amyloid in Inclusion Body Myositis and Differentiation from Polymyositis

    Lilleker, J., Hodgson, R., Roberts, M. E., Herholz, K., Howard, J., Hinz, R. & Chinoy, H., 2019, In : Annals Of Rheumatic Diseases.

    Research output: Contribution to journalArticle

  5. Published

    Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease

    Alzheimer Precision Medicine Initiative (APMI), 2019, In : Alzheimer's and Dementia.

    Research output: Contribution to journalArticle

  6. 2018
  7. Published

    Validation of a realistic simulation of the HRRT using SimSET

    Raptis, E., Parkes, L., Anton-Rodriguez, J., Carter, S., Herholz, K. & Matthews, J., 15 Nov 2018. 5 p.

    Research output: Contribution to conferencePaper

  8. Published

    Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease

    EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9

    Research output: Contribution to journalArticle

  9. Published

    Quantifying muscle amyloid content in inclusion body myositis using [18f] florbetapir positron emission tomography

    Lilleker, J., Hodgson, R., Roberts, M. E., Herholz, K., Howard, J., Hinz, R. & Chinoy, H., Jun 2018, In : EUROPEAN JOURNAL OF NEUROLOGY. 25, p. 84-85

    Research output: Contribution to journalMeeting Abstract

  10. Published

    Functional neuroanatomical associations of working memory in early-onset Alzheimer's disease

    Kobylecki, C., Haense, C., Harris, J., Stopford, C., Segobin, S., Jones, M., Richardson, A., Gerhard, A., Anton-Rodriguez, J., Thompson, J., Herholz, K. & Snowden, J., Jan 2018, In : International journal of geriatric psychiatry. 33, 1, p. 176-184

    Research output: Contribution to journalArticle

  11. Published

    Basal forebrain volume, but not hippocampal volume, is a predictor of global cognitive decline in patients with alzheimer's disease treated with cholinesterase inhibitors

    Alzheimer's Disease Neuroimaging Initiative & Alzheimer Precision Medicine Initiative (APMI), 2018, In : Frontiers in Neurology. 9, AUG, 642.

    Research output: Contribution to journalArticle

  12. Published

    Dual-phase [18F]florbetapir in frontotemporal dementia

    Asghar, M., Hinz, R., Herholz, K. & Carter, S. F., 2018, In : European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...19 Next